Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Schedule-dependent topoisomerase II-inhibiting drugs
S P Joel, M L Slevin
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1993
Prolonged oral etoposide in small cell lung cancer
M L Slevin, S P Joel
British Journal of Cancer
|
December 22, 1999
Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines
R H te Poele, S P Joel
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Etoposide dosage and pharmacodynamics
S P Joel, R Shah, M L Slevin
Journal of Chromatography
|
September 9, 1988
An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites
S P Joel, R J Osborne, M L Slevin
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Stability of the i.v. and oral formulations of etoposide in solution
S P Joel, P I Clark, M L Slevin
British Journal of Cancer
|
May 3, 2002
The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR-ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents
W M Liu, L A Stimson, S P Joel
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2002
The importance of drug scheduling and recovery phases in determining drug activity. Improving etoposide efficacy in BCR-ABL-positive CML cells
W M Liu, A J Lawrence, S P Joel
Journal of Pharmaceutical and Biomedical Analysis
|
March 1, 1994
Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma
D J Chapman, S P Joel, G W Aherne
Leukemia
|
August 30, 2002
Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines
W M Liu, P R Oakley, S P Joel
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Schedule-dependent topoisomerase II-inhibiting drugs
S P Joel, M L Slevin
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1993
Prolonged oral etoposide in small cell lung cancer
M L Slevin, S P Joel
British Journal of Cancer
|
December 22, 1999
Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines
R H te Poele, S P Joel
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Etoposide dosage and pharmacodynamics
S P Joel, R Shah, M L Slevin
Journal of Chromatography
|
September 9, 1988
An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites
S P Joel, R J Osborne, M L Slevin
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Stability of the i.v. and oral formulations of etoposide in solution
S P Joel, P I Clark, M L Slevin
British Journal of Cancer
|
May 3, 2002
The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR-ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents
W M Liu, L A Stimson, S P Joel
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2002
The importance of drug scheduling and recovery phases in determining drug activity. Improving etoposide efficacy in BCR-ABL-positive CML cells
W M Liu, A J Lawrence, S P Joel
Journal of Pharmaceutical and Biomedical Analysis
|
March 1, 1994
Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma
D J Chapman, S P Joel, G W Aherne
Leukemia
|
August 30, 2002
Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines
W M Liu, P R Oakley, S P Joel
Page
of 5